Sumitomo Mitsui Trust Group, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in CRSP
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$88,188,833
-$14,494,507 QoQ
Shares Held
1,853,875
-5.3% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,209,271,805 across 38 Biotechnology names. CRSP ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
614,448 | $274,375,609 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,669 | $211,447,616 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,054,294 | $107,357,404 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,417 | $104,031,152 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
3,825,585 | $91,163,690 | |
| 6 | CRSP |
CRISPR Therapeutics AG
This page
|
1,853,875 | $88,188,833 | |
| 7 | INSM |
INSMED Inc
|
501,282 | $81,969,632 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,273,705 | $61,099,628 |
All Filings in CRSP
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $88,188,833 | 1,853,875 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $102,683,340 | 1,958,111 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $140,227,776 | 2,163,675 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $117,457,720 | 2,414,838 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $86,432,422 | 2,539,889 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $108,069,807 | 2,745,676 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $139,438,237 | 2,968,034 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $170,213,271 | 3,151,514 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $222,800,385 | 3,268,785 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $210,947,101 | 3,369,762 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $157,297,683 | 3,465,470 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $198,362,661 | 3,533,357 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $179,706,931 | 3,973,180 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $162,863,249 | 4,006,476 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $278,569,797 | 4,262,736 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $278,575,635 | 4,584,098 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $289,981,519 | 4,619,747 | Shares | Defined | 2022-04-27 | |
| No filing history on record for this holder in this stock. | ||||||